MAULDIN JOHN F 4
4 · AgeX Therapeutics, Inc. · Filed Mar 20, 2019
Insider Transaction Report
Form 4
MAULDIN JOHN F
Director
Transactions
- Sale
Warrant to Purchase Common Stock
2019-03-15$1.65/sh−50,000$82,500→ 0 total(indirect: Retirement Plans)Exercise: $2.50From: 2018-11-27Exp: 2019-03-18→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Warrants held in retirement plans of companies controlled by Mr. Mauldin.